Equinor ASA ADR (EQNR) concluded trading on Thursday at a closing price of $26.39, with 3.13 million shares of worth about $82.65 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 12.52% during that period and on June 12, 2025 the price saw a gain of about 1.81%. Currently the company’s common shares owned by public are about 2.73B shares, out of which, 2.73B shares are available for trading.
Stock saw a price change of 8.91% in past 5 days and over the past one month there was a price change of 11.68%. Year-to-date (YTD), EQNR shares are showing a performance of 13.09% which decreased to -2.17% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $21.41 but also hit the highest price of $27.83 during that period. The average intraday trading volume for Equinor ASA ADR shares is 3.87 million. The stock is currently trading 8.99% above its 20-day simple moving average (SMA20), while that difference is up 11.73% for SMA50 and it goes to 10.62% higher than SMA200.
Equinor ASA ADR (NYSE: EQNR) currently have 2.73B outstanding shares and institutions hold larger chunk of about 2.67% of that.
The stock has a current market capitalization of $72.16B and its 3Y-monthly beta is at 0.56. PE ratio of stock for trailing 12 months is 8.33, while it has posted earnings per share of $3.17 in the same period. It has Quick Ratio of 1.27 while making debt-to-equity ratio of 0.65. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for EQNR, volatility over the week remained 0.84% while standing at 1.54% over the month.
Stock’s fiscal year EPS is expected to drop by -8.27% while it is estimated to increase by 1.22% in next year. EPS is likely to shrink at an annualized rate of -0.41% for next 5-years, compared to annual growth of 41.31% made by the stock over the past 5-years.
On May 20, 2025, Berenberg Downgrade their recommendations, while on May 12, 2025, Morgan Stanley Downgrade their ratings for the stock with a price target of $22.70. Stock get a Neutral rating from JP Morgan on May 07, 2025.
